Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

CD34 is crucial for skin tumor development in mice.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

CD34 marks potential stem cells in dog hair follicles.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

CD44 signaling can help heal wounds without scars.

Targeting CD169+ skin macrophages may help treat psoriasis.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Most people with scarring and nonscarring hair loss show similar D2-40 levels, but some with scarring hair loss have higher levels.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

CD44 variant changes start alopecia areata, but don't maintain it.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.